haemophilu
parasui
caus
diseas
syndrom
polyseros
mening
arthriti
swine
previou
studi
h
parasui
reveal
virul
dispar
among
isol
inconsist
heterolog
protect
studi
virul
direct
transmiss
heterolog
protect
isol
h
parasui
mnh
evalu
use
highli
suscept
pig
model
initi
experi
isol
mnh
caus
diseas
strain
fail
caus
clinic
sign
diseas
one
pig
group
challeng
mnh
fail
develop
clinic
diseas
abl
transmit
h
parasui
noninfect
pig
subsequ
develop
diseas
pig
colon
mnh
free
clinic
diseas
protect
subsequ
challeng
isol
follow
experi
pig
vaccin
strain
given
either
bacterin
intramuscularli
live
intranas
vaccin
protect
subsequ
challeng
isol
howev
pig
given
live
develop
arthriti
overal
studi
demonstr
pig
infect
virul
isol
h
parasui
remain
healthi
serv
reservoir
transmiss
naiv
pig
heterolog
protect
among
h
parasui
isol
possibl
addit
attenu
strain
necessari
use
live
vaccin
h
aemophilu
parasui
gramneg
naddepend
bacterium
famili
pasteurellacea
caus
diseas
swine
character
system
invas
bacteremia
result
syndrom
character
polyseros
periton
pleuriti
pericard
mening
arthriti
clinic
sign
diseas
includ
fever
depress
anorexia
swollen
joint
lame
dyspnea
central
nervou
system
sign
develop
diseas
sporad
devast
occur
h
parasui
also
caus
pneumonia
swine
without
sign
system
diseas
diseas
pattern
suggest
matern
antibodi
may
provid
earli
protect
allow
piglet
colon
without
result
diseas
develop
activ
immun
respons
support
experiment
studi
demonstr
exposur
neonat
piglet
predomin
virul
strain
farm
use
method
prophylaxi
also
difficult
experiment
reproduc
system
diseas
convent
rear
pig
colostrumdepriv
pig
often
use
experiment
model
variou
practic
earli
wean
may
result
intermitt
colon
piglet
result
exposur
bacterium
pig
mix
nurseri
later
matern
antibodi
level
wane
elev
health
statu
may
result
lack
specif
matern
antibodi
divers
number
strain
leav
piglet
vulner
coinfect
bacteria
virus
may
also
increas
suscept
infect
diseas
fifteen
serovar
h
parasui
identifi
mani
isol
nontyp
serovar
isol
frequent
conjunct
clinic
diseas
unit
state
experiment
evid
indic
h
parasui
may
colon
nasal
caviti
trachea
initi
result
loss
cilia
damag
ciliat
epithelium
even
though
organ
appear
close
associ
cell
damag
mucos
epitheli
cell
may
facilit
invas
h
parasui
also
shown
invad
epitheli
endotheli
cell
vitro
initi
colon
bacteri
invas
result
bacteremia
system
spread
h
parasui
virul
associ
serum
phagocytosi
resist
abil
invad
endotheli
cell
specif
virul
factor
larg
unknown
capsul
certain
variant
trimer
autotransport
vtaa
found
associ
pathogen
strain
phagocytosi
resist
outer
membran
protein
associ
serum
resist
unusu
number
differ
strain
found
herd
even
anim
believ
nonpathogen
strain
commonli
colon
nasal
caviti
swine
report
mix
degre
heterolog
protect
among
strain
may
due
related
strain
exposur
live
bacteria
mucos
surfac
versu
bacterin
given
parenter
prior
colon
statu
anim
current
studi
examin
virul
direct
transmiss
heterolog
protect
isol
h
parasui
highli
suscept
popul
pig
initi
experi
isol
found
pathogen
mnh
one
caus
sign
diseas
despit
colon
nasal
caviti
also
demonstr
direct
transmiss
virul
isol
clinic
healthi
anim
naiv
pig
result
system
diseas
second
experi
heterolog
protect
demonstr
use
isol
either
bacterin
live
vaccin
howev
arthriti
occur
pig
vaccin
live
indic
attenu
strain
would
necessari
use
live
vaccin
h
parasui
isol
inocula
h
parasui
serovar
isol
cultur
lung
pig
diseas
previous
shown
virul
colostrumdepriv
pig
h
parasui
isol
lung
pig
diseas
also
coinfect
porcin
reproduct
respiratori
syndrom
viru
react
serovar
type
serum
well
report
nontyp
h
parasui
mnh
serovar
isol
sever
epidem
mortal
pig
sign
consist
diseas
porcin
circoviru
type
bovin
viral
diarrhea
viru
pasteurella
multocida
arcanobacterium
pyogen
also
isol
outbreak
mnh
isol
h
parasui
serovar
refer
strain
isol
nasal
caviti
healthi
pig
prepar
inocula
h
parasui
isol
cultur
casman
agar
supplement
hors
serum
nad
co
h
cultur
suspens
prepar
phosphatebuff
salin
pb
typic
yield
approxim
cfuml
pig
inocul
intranas
ml
mlnostril
suspens
pb
use
sham
inoculum
bacterin
prepar
strain
h
parasui
cultur
casman
agar
co
h
cultur
suspens
prepar
pb
subsequ
buffer
formalin
ad
final
concentr
prepar
allow
sit
room
temperatur
overnight
mix
store
casman
plate
streak
l
undilut
prepar
growth
observ
h
incub
co
suspens
centrifug
min
g
pellet
wash
pb
resuspend
combin
pb
emulsigen
adjuv
suffici
yield
equival
cfuml
adjuv
sourc
pig
pig
anim
experi
obtain
experiment
herd
origin
pig
facil
deriv
caesarianderiv
colostrumdepriv
cdcd
methodolog
maintain
hepafilt
barrier
irradi
pig
feed
filter
chlorin
uvtreat
water
pig
deriv
popul
rais
facil
normal
product
method
sentinel
pig
euthan
monthli
full
diagnost
workup
conduct
ensur
freedom
swine
pathogen
addit
unexpect
clinic
sign
mortal
pig
also
euthan
given
full
diagnost
workup
diagnost
monitor
includ
gross
patholog
histopatholog
serolog
viru
isol
fecal
float
electron
microscopi
bacteri
cultur
select
immunofluoresc
test
immunohistochemistri
procedur
select
molecular
diagnost
test
includ
pcr
mani
agent
screen
multipl
procedur
pathogen
herd
origin
determin
free
diagnost
test
follow
actinobacillu
spp
giardia
spp
pseudora
origin
pig
deriv
larg
white
landrac
femal
boar
larg
white
landrac
femal
synthet
sire
line
pic
mate
program
design
minim
inbreed
sow
bred
fresh
artifici
insemin
gestat
individu
pen
farrow
tradit
farrow
crate
wean
pig
move
growth
pen
appropri
feed
pig
age
given
antibiot
feed
water
inject
vaccin
ever
use
period
facil
deriv
start
studi
anim
move
sourc
herd
nation
anim
diseas
center
hous
biosafeti
level
anim
isol
facil
care
complianc
within
guidelin
nation
anim
diseas
center
institut
anim
care
use
committe
nasal
swab
taken
pig
day
anim
experi
began
neg
h
parasui
cultur
experi
design
twentyf
pig
litter
distribut
group
pig
group
contain
pig
litter
one
day
old
pig
fourth
litter
day
old
one
group
challeng
intranas
isol
h
parasui
mnh
sham
inocul
pb
cultur
dilut
indic
inocula
contain
cfuml
cfuml
cfuml
cfuml
mnh
one
week
challeng
nasal
swab
taken
surviv
pig
one
shaminocul
pig
cohous
healthi
survivor
mnh
group
three
week
challeng
nasal
swab
taken
surviv
pig
rechalleng
intranas
cfu
h
parasui
isol
cours
experi
pig
examin
clinic
sign
approxim
everi
h
except
overnight
period
pig
show
sign
diseas
joint
swell
lame
incoordin
tremor
sever
depress
reluct
move
immedi
euthan
remain
pig
euthan
day
secondari
challeng
time
euthanasia
swab
nasal
caviti
lung
joint
abdomin
caviti
thorac
caviti
mening
collect
agit
ml
pb
l
cultur
casman
plate
experi
design
eighteen
pig
differ
litter
week
old
randomli
divid
group
group
consist
pig
intramuscularli
im
vaccin
bacterin
made
h
parasui
strain
one
millilit
adjuv
bacterin
given
twice
day
week
later
group
consist
pig
given
intranas
live
vaccin
day
experi
group
n
n
consist
nonvaccin
pig
day
experi
pig
group
challeng
intranas
cfu
h
parasui
isol
nasal
swab
taken
day
experi
blood
collect
sera
day
challeng
h
parasui
isol
pig
examin
clinic
sign
approxim
everi
h
except
overnight
period
pig
show
sign
diseas
euthan
immedi
surviv
pig
euthan
day
challeng
time
euthanasia
swab
collect
cultur
describ
experi
serolog
sera
collect
experi
submit
univers
minnesota
veterinari
diagnost
laboratori
run
h
parasui
oppa
enzymelink
immunosorb
assay
elisa
assay
also
perform
use
sera
vaccin
pig
evalu
antibodymedi
complement
kill
homolog
heterolog
strain
h
parasui
determin
correl
protect
heatinactiv
hi
preand
postvaccin
sera
pig
experi
use
antibodi
sourc
individu
nonhi
serum
cdcd
pig
use
complement
sourc
sampl
test
l
hi
serum
heat
h
pig
ad
l
nonhi
cdcd
serum
one
well
plate
follow
addit
l
cfu
h
parasui
prepar
method
inoculum
pig
studi
sampl
incub
h
serial
dilut
sampl
cultur
duplic
casman
plate
plate
incub
h
coloni
count
control
number
cfu
inoculum
number
cfu
incub
l
hi
cdcd
serum
number
cfu
incub
l
hi
cdcd
serum
plu
l
nonhi
cdcd
serum
also
determin
statist
prism
softwar
version
graphpad
softwar
san
diego
ca
use
statist
analys
twoway
analysi
varianc
anova
bonferroni
multiplecomparison
posttest
use
analyz
serolog
data
pig
challeng
isol
h
parasui
determin
isol
pathogen
virul
naiv
pig
model
infect
pig
challeng
h
parasui
isol
mnh
develop
sign
diseas
includ
joint
swell
lame
tremor
depress
reluct
move
pig
challeng
isol
one
die
without
premonitori
sign
day
postinfect
rest
euthan
due
sign
diseas
day
postinfect
four
pig
inocul
isol
euthan
due
sign
diseas
day
postinfect
pig
inocul
isol
mnh
euthan
due
sign
diseas
day
postinfect
gross
lesion
observ
pig
typic
consist
seros
effus
ambercolor
fluid
mild
pneumonia
signific
fibrin
deposit
seros
surfac
observ
one
pig
mnhchalleng
group
pig
challeng
strain
remain
healthi
show
sign
diseas
throughout
experi
h
parasui
isol
nasal
swab
surviv
infect
pig
week
week
postinfect
indic
pig
colon
none
shaminocul
pig
develop
diseas
h
parasui
isol
nasal
swab
taken
pig
tabl
summar
age
pig
euthan
site
h
parasui
cultur
one
week
initi
challeng
one
shaminocul
pig
place
survivor
challeng
isol
mnh
determin
colon
clinic
healthi
pig
would
transmit
h
parasui
naiv
pig
caus
diseas
five
day
naiv
pig
place
mnh
survivor
contact
pig
show
sign
diseas
euthan
pig
gross
lesion
polyseros
larg
amount
fibrin
deposit
seros
surfac
h
parasui
isol
site
sampl
except
mening
seven
day
naiv
pig
place
survivor
contact
pig
becam
lame
swollen
hock
euthan
h
parasui
isol
nasal
caviti
joint
three
week
primari
challeng
surviv
pig
shaminocul
pig
naiv
pig
pig
mnhchalleng
pig
challeng
intranas
h
parasui
isol
determin
whether
would
protect
heterolog
challeng
one
naiv
pig
die
without
premonitori
sign
day
postchalleng
naiv
pig
euthan
day
postchalleng
due
sign
diseas
gross
find
cultur
result
similar
pig
origin
challeng
isol
pig
previous
inocul
isol
mnh
pig
previous
inocul
remain
healthi
pig
euthan
day
secondari
challeng
gross
lesion
note
h
parasui
isol
nasal
caviti
lung
pig
origin
inocul
isol
nasal
caviti
pig
origin
inocul
isol
mnh
nasal
caviti
pig
origin
inocul
isol
h
parasui
isol
system
site
joint
abdomin
caviti
thorac
caviti
mening
pig
experi
second
experi
conduct
explor
whether
strain
could
induc
heterolog
protect
given
either
bacterin
im
live
intranas
vaccin
pig
group
intranas
inocul
live
cultur
develop
swollen
hock
lame
day
postinocul
h
parasui
cultur
joint
tap
perform
one
pig
dna
sequenc
analysi
gene
isol
reveal
sequenc
ident
sequenc
gene
otherwis
uniqu
cultur
collect
also
uniqu
among
h
parasui
complet
sequenc
current
avail
genbank
pig
develop
lame
treat
one
inject
ceftiofur
exced
pfizer
accord
drug
label
recov
unev
h
parasui
isol
nasal
swab
pig
inocul
live
day
postinocul
regardless
treatment
ceftiofur
onehalf
pig
day
postinocul
h
parasui
isol
nasal
swab
pig
group
time
challeng
isol
h
parasui
nonvaccin
pig
group
develop
sign
diseas
includ
lethargi
swollen
joint
lame
neurolog
sign
pig
euthan
day
postchalleng
h
parasui
isol
nasal
caviti
trachea
least
system
site
thorac
caviti
abdomin
caviti
joint
andor
mening
pig
lung
pig
clinic
sign
seen
pig
group
vaccin
im
bacterin
intranas
live
cultur
nonvaccin
nonchalleng
pig
group
ten
day
challeng
pig
group
euthan
necropsi
gross
lesion
observ
h
parasui
isol
nasal
caviti
pig
group
group
site
serolog
three
pig
vaccin
im
bacterin
none
pig
group
posit
h
parasui
antibodi
measur
oppa
elisa
use
sera
taken
prior
challeng
isol
experiment
day
data
shown
sera
pig
experi
evalu
evalu
antibodymedi
complement
kill
homolog
heterolog
strain
h
parasui
determin
vitro
phenotyp
correl
vivo
protect
perform
serum
sensit
assay
use
h
parasui
strain
fig
small
statist
signific
reduct
number
viabl
cell
exposur
nonhi
cdcd
serum
hi
cdcd
serum
fig
addit
reduct
viabl
bacteria
seen
either
h
parasui
strain
prevaccin
sera
use
antibodi
sourc
assay
fig
c
convers
statist
signific
reduct
viabil
sera
collect
day
postvaccin
use
antibodi
sourc
fig
c
sera
nonvaccin
pig
day
result
moder
though
signific
reduct
bacteria
well
reduct
less
statist
differ
observ
postvaccin
sera
fig
c
differ
kill
sera
collect
pig
vaccin
bacterin
live
fig
ceftiofur
treatment
signific
impact
develop
antibodi
respons
follow
live
immun
abil
kill
found
significantli
differ
postvaccin
sera
collect
treat
nontreat
pig
compar
fig
specif
sera
collect
pig
treat
ceftiofur
abl
complet
kill
howev
kill
capac
sera
pig
treat
ceftiofur
ident
sera
bacterinimmun
pig
differ
sensit
seen
strain
kill
postvaccin
sera
ceftiofurtr
pig
use
antibodi
sourc
data
shown
date
littl
known
genet
differ
among
h
parasui
isol
genet
factor
contribut
h
parasui
virul
one
goal
studi
directli
compar
virul
set
h
parasui
isol
identifi
strain
diverg
virul
futur
genom
sequenc
comparison
base
previou
experiment
work
andor
diagnost
inform
expect
isol
mnh
would
pathogen
variou
virul
strain
would
nonpathogen
result
experi
indic
isol
capabl
caus
system
diseas
diseas
develop
rapidli
pig
challeng
isol
h
parasui
isol
numer
system
site
diseas
sign
develop
slightli
later
group
challeng
mnh
one
pig
remain
healthi
group
h
parasui
broadli
distribut
pig
challeng
challeng
mnh
interestingli
survivor
mnh
group
litter
youngest
pig
challeng
may
coincid
possibl
age
genet
effect
system
diseas
progress
fourth
strain
caus
observ
diseas
experi
second
experi
howev
h
parasui
genet
evid
confirm
strain
isol
arthrit
joint
pig
recov
quickli
without
complic
treatment
ceftiofur
unknown
whether
diseas
would
progress
treatment
initi
strain
believ
nonpathogen
base
previou
report
given
either
intranas
intraperiton
specificpathogenfre
pig
result
clinic
sign
diseas
gross
lesion
seen
necropsi
strain
origin
isol
nasal
caviti
healthi
pig
strain
along
type
strain
serovar
virul
given
intraperiton
guinea
pig
howev
given
intratrach
rout
guinea
pig
transient
clinic
sign
minim
evid
infect
present
necropsi
contrast
result
type
strain
consid
virul
caus
diseas
rout
thu
although
strain
appear
less
virul
other
retain
abil
caus
system
diseas
certain
condit
yet
fulli
identifi
direct
transmiss
h
parasui
intranas
challeng
pig
clinic
sign
diseas
naiv
pig
shown
occur
previous
current
studi
naiv
pig
place
direct
contact
healthi
pig
colon
mnh
display
clinic
sign
diseas
within
week
sourc
pig
continu
remain
healthi
result
indic
subclin
infect
virul
strain
occur
pig
anim
serv
reservoir
transmiss
addit
result
provid
evid
h
parasui
isol
cultur
upper
respiratori
tract
healthi
pig
necessarili
avirul
view
result
first
experi
second
experi
design
test
whether
strain
could
use
vaccin
determin
whether
administ
live
intranas
vaccin
would
offer
better
protect
bacterin
gener
shown
piglet
vaccin
bacterin
protect
challeng
homolog
strain
h
parasui
howev
report
inconsist
degre
protect
afford
bacterinvaccin
piglet
subsequ
challeng
heterolog
strain
furthermor
evid
virul
vaccin
strain
may
make
differ
degre
protect
seen
bacterin
convers
small
experi
examin
virul
h
parasui
strain
pig
expos
aerosol
nonpathogen
serotyp
later
resist
challeng
virul
isol
indic
mucos
exposur
live
bacteria
may
induc
crossprotect
immun
studi
protect
heterolog
challeng
given
bacterin
live
vaccin
given
prior
report
expect
live
vaccin
superior
bacterin
induc
heterolog
protect
live
bacteri
vaccin
shown
mani
case
effect
elicit
broad
immun
respons
involv
antibodyand
cellmedi
immun
also
live
vaccin
often
superior
stimul
mucos
immun
may
crucial
control
h
parasui
colon
diseas
variabl
result
previou
studi
examin
crossprotect
bacterin
may
explain
examin
related
isol
use
studi
andor
prior
colonizationimmun
statu
piglet
use
instanc
young
pig
matern
deriv
immun
often
interfer
develop
activ
immun
respons
vaccin
especi
bacterin
larg
induc
system
antibodi
respons
sinc
use
naiv
pig
interfer
would
occur
thu
whether
vaccin
would
equal
efficaci
face
matern
immun
still
need
investig
unfortun
fact
demonstr
virul
make
less
attract
candid
live
vaccin
howev
ration
attenu
may
make
suitabl
candid
identif
nonpathogen
strain
may
undertaken
current
carri
sequenc
virul
comparison
strain
h
parasui
isol
may
identifi
virul
factor
possibl
attenu
target
develop
better
vaccin
h
parasui
factor
correl
protect
need
identifi
particular
antemortem
serolog
antibodi
assay
ideal
target
thu
use
sera
pig
experi
evalu
vaccineinduc
antibodi
antibodymedi
complement
kill
assay
reveal
interest
result
first
littl
differ
strain
sensit
kill
nonimmun
sera
obtain
cdcd
pig
somewhat
contradictori
previou
report
indic
nasal
isol
consid
low
virul
sensit
serum
kill
test
previou
report
although
nasal
isol
test
sensit
complement
kill
previou
report
rang
suscept
seen
isol
fact
observ
pathogen
capabl
may
explan
inconsist
also
sourc
sera
use
differ
studi
previou
one
studi
use
swine
sera
cdcd
pig
complement
sourc
heatinactiv
sera
experiment
anim
antibodi
sourc
previou
studi
sera
convent
anim
use
thu
level
specif
nonspecif
antibodi
may
differ
sera
use
two
studi
differ
cultur
condit
may
alter
characterist
capsul
product
could
account
discrep
well
postvaccin
sera
much
effect
kill
h
parasui
prevaccin
sera
also
contrast
prior
report
wherein
use
immun
serum
increas
sensit
h
parasui
complement
kill
may
due
individu
strain
experiment
specif
differ
experi
previou
report
antibodi
rais
highli
virul
strain
nagasaki
appear
enhanc
serum
sensit
homolog
strain
heterolog
strain
nasal
system
isol
certain
highli
virul
strain
like
nagasaki
may
resist
kill
whether
homolog
antibodi
present
potenti
due
inher
trait
capsul
type
product
natur
antibodi
respons
induc
nagasaki
strain
may
differ
part
reason
high
virul
potenti
crossreact
induc
antibodi
may
specif
particular
strain
use
studi
well
may
explain
lack
antibodyenhanc
kill
previou
studi
gener
postvaccin
sera
studi
effect
kill
strain
possibl
due
heterolog
specif
antibodi
slight
increas
sensit
strain
sera
nonvaccin
pig
taken
day
experi
compar
sera
day
possibl
explan
phenomenon
exposur
commens
bacteri
flora
time
may
induc
nonspecif
crossreact
antibodi
outer
membran
protein
implic
confer
serum
resist
h
parasui
mutant
lack
shown
induc
complement
activ
classic
pathway
bind
igg
outer
membran
protein
anoth
interest
find
antibodymedi
complement
kill
assay
differ
postvaccin
sera
ceftiofurtr
nontreat
pig
given
live
vaccin
regard
abil
kill
isol
sera
pig
treat
antibiot
effect
mediat
kill
sera
ceftiofurtr
pig
import
note
treatment
ceftiofur
effect
clear
h
parasui
nasal
caviti
system
invas
h
parasui
antibiotictr
pig
fail
induc
enhanc
system
antibodi
respons
suffici
achiev
increas
complementmedi
antibodydepend
kill
elisa
detect
serum
igg
specif
oppa
protein
develop
oppaspecif
antibodi
appear
occur
select
survivor
system
diseas
healthi
colon
pig
oliveira
person
commun
howev
pig
given
bacterin
develop
oppaspecif
serum
antibodi
respons
none
pig
given
live
vaccin
develop
oppaspecif
serum
antibodi
respons
regardless
ceftiofur
treatment
possibl
live
nonceftiofurtr
pig
clinic
inappar
system
infect
andor
establish
infect
lower
respiratori
tract
result
obviou
clinic
diseas
result
develop
antibodi
respons
significantli
aid
abil
kill
data
provid
evid
intranas
deliveri
live
strain
h
parasui
induc
broader
antibodi
respons
howev
ration
attenu
like
necessari
prevent
vaccineinduc
diseas
pig
use
experi
uniqu
obtain
experiment
herd
kept
isol
ultraclean
barrier
environ
transgen
research
purpos
origin
stock
deriv
caesarian
section
subsequ
gener
allow
farrow
suckl
normal
consist
test
neg
common
swine
pathogen
previou
challeng
studi
undertaken
convent
pig
h
parasui
strain
use
studi
provid
result
entir
consist
report
abl
sporad
reproduc
system
diseas
strain
convent
pig
often
pig
respiratori
tract
becom
colon
mild
pneumonia
result
unpublish
data
result
obtain
pig
use
studi
also
support
concept
diseas
occur
absenc
coinfect
common
pig
virus
porcin
reproduct
respiratori
syndrom
viru
porcin
circoviru
thu
pig
use
current
studi
appear
exquisit
suscept
challeng
h
parasui
great
use
virul
studi
would
necessari
use
colostrumdepriv
pig
combin
anim
challeng
studi
genom
comparison
way
laboratori
help
identifi
differ
among
strain
dispar
virul
profil
hope
lead
discoveri
virul
factor
potenti
immunolog
target
vaccin
develop
bioinformat
approach
use
discov
gene
conserv
among
strain
well
uniqu
result
provid
basi
test
role
potenti
virul
gene
swine
infect
studi
may
also
allow
develop
detect
assay
discrimin
strain
high
low
virul
